Brian Park, PharmD

Drug Information Specialist https://www.pulmonologyadvisor.com

Brian Park, PharmD, is a Drug Information Specialist at MPR. A graduate of the Ernest Mario School of Pharmacy, Rutgers University, Brian worked as a pharmacy manager at Stop & Shop Pharmacy for 8 years. He is a certified diabetes care pharmacist.

All articles by Brian Park, PharmD

Tuberculosis

Pretomanid Approved as Part of New Regimen for Drug-Resistant Tuberculosis

Brian Park, PharmD

August 19, 2019

The FDA has approved pretomanid tablets (TB Alliance) in combination with bedaquiline and linezolid for the treatment of adults with pulmonary extensively drug resistant (XDR), treatment-intolerant or nonresponsive multidrug-resistant (MDR) tuberculosis (TB).

Next post in Tuberculosis

Brian Park, PharmD

All articles by Brian Park, PharmD

Pretomanid Approved as Part of New Regimen for Drug-Resistant Tuberculosis

Bedaquiline Approved to Treat Adolescent Patients With Multidrug-Resistant TB